Company
Headquarters: Bubendorf, Switzerland
Employees: 1,639
CHF4.49 Billion
CHF as of Jan. 1, 2026
US$5.67 Billion
| Company | Market Cap (USD) |
|---|---|
| Air Liquide SA | $108.08 B |
| Shin-Etsu Chemical Co Ltd | $56.20 B |
| Air Products and Chemicals, Inc. | $55.75 B |
| BASF SE | $46.95 B |
| Saudi Basic Industries Corp | $41.12 B |
| Company | Market Cap (USD) |
|---|---|
| Linde | $201.21 B |
| BHP | $151.21 B |
| Zijin Mining Group Co Ltd | $134.18 B |
| Rio Tinto | $131.23 B |
| Southern Copper Corporation | $121.79 B |
Bachem Holding AG, a technology-based biochemicals company, provides services to the pharmaceutical and biotechnology industries primarily in Switzerland, the United States, Germany, Ireland, the United Kingdom, Austria, Japan, and internationally. It develops and manufactures peptide and oligonucleotides as active pharmaceutical ingredients (APIs), as well as biochemicals for research purposes. The company offers research products, which include peptides, amino acid derivatives, and biochemicals for peptide research; and custom synthesis services. It also provides API products comprising generic APIs used in the fields of cancer, diabetes, obesity, fertility, and others; and peptides for new chemical entities. In addition, the company offers oligonucleotide-based APIs, as well as customer support services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG is a subsidiary of Ingro Finanz AG.
| Last Financial Reports Date | June 30, 2025 |
| Revenue TTM | CHF677.9 M |
| EBITDA | CHF184.6 M |
| Gross Profit TTM | CHF211.7 M |
| Profit Margin | 19.79% |
| Operating Margin | 21.38% |
| Quarterly Revenue Growth | 30.20% |
Bachem Holding AG has the following listings and related stock indices.
Stock: SIX: BANB wb_incandescent
Stock: OTC: BFEHF wb_incandescent